Huons Group targets Middle East market at Dubai Derma 2026

Huons Group participated in Dubai Derma 2026, a major international dermatology and aesthetic medicine conference held at the Dubai World Trade Center from January 8 to 10. The group utilized the platform to expand its presence in the Middle East and North Africa (MENA) and Indian subcontinent markets.

Key subsidiaries showcased specialized medical products: Humedix presented its 'elravie' aesthetic filler brand and conducted clinical seminars on K-beauty principles. Huons Meditech exhibited its 'Dermashine Pro' and the new 'Dermashine DUO RF,' a hybrid device combining radiofrequency stimulation with drug injection to reduce treatment time and pain. Huons Biopharma promoted its botulinum toxin product, 'Hutox,' which has already secured product approvals in 17 countries, including China, Russia, Thailand, and Iraq, with further regulatory processes underway in Brazil.

The group aims to strengthen local partnerships and expand its product portfolio within the Middle East through integrated clinical education and business development strategies.